- Home
- OMF vs CORT Comparison
OMF vs CORT Comparison
Compare OMF & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OMF | CORT |
|---|---|---|
| Founded | 1920 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 3.7B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | OMF | CORT |
|---|---|---|
| Price | $63.56 | $35.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | $68.23 | ★ $111.00 |
| AVG Volume (30 Days) | 1.0M | ★ 2.9M |
| Earning Date | 02-05-2026 | 02-25-2026 |
| Dividend Yield | ★ 6.42% | N/A |
| EPS Growth | ★ 29.36 | N/A |
| EPS | ★ 5.90 | 0.87 |
| Revenue | ★ $2,892,000,000.00 | $741,172,000.00 |
| Revenue This Year | $72.81 | $21.70 |
| Revenue Next Year | $8.39 | $30.13 |
| P/E Ratio | ★ $11.09 | $39.76 |
| Revenue Growth | 16.10 | ★ 17.92 |
| 52 Week Low | $38.00 | $32.99 |
| 52 Week High | $71.93 | $117.33 |
Technical Indicators
Market Signals| Indicator | OMF | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 37.35 | 20.75 |
| Support Level | $64.78 | $34.28 |
| Resistance Level | $71.93 | $37.48 |
| Average True Range (ATR) | 1.68 | 2.73 |
| MACD | -0.91 | -0.66 |
| Stochastic Oscillator | 4.26 | 4.02 |
Price Performance
Historical ComparisonAbout OMF OneMain Holdings Inc.
OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company's reportable segment is Consumer and Insurance. The main source of revenue is net interest income.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.